-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
March 01, 2016 - women-hiv-protocol-160301
Source: www.effectivehealthcare.ahrq.gov
Published online: March 1, 2016
Evidence-based Practice Center Technical Br ief Protocol
Strategies for Improving the Lives of Women Aged 40 and Above Living with HIV/AIDS
I. Background and Objectives for the Systematic Review
It is p…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
January 01, 2024 - instability-high [MSI-H] or
mismatch repair-deficient [MMR-deficient], claudin, human epidermal growth factor … oxaliplatin and docetaxel; FOLFOX
= leucovorin, fluorouracil, and oxaliplatin; HER2 = human epidermal growth factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
June 01, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: April 15, 2010
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Progestogens for the Prevention of Preterm B…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - Chicago, Chicago, IL
Introduction
In epidemiology, the term “exposure” can be broadly
applied to any factor … readily
available (existing) data elements to identify whether
individuals have been exposed to a factor … of the key considerations in study design is
how to determine and then characterize exposure
to a factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-education-protocol.pdf
January 01, 2018 - Research Protocol: Characteristics of Existing Asthma Self-Management Education Packages
1
Evidence-based Practice Center
Technical Brief Protocol
Project Title: Characteristics of Existing Asthma Self-Management
Education Packages
I. Background and Objectives for the Technical Brief
Asthma is a ch…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-equity-protocol.pdf
January 01, 2020 - EPC Systematic Review Protocol: Achieving Health Equity in Preventive Services: Systematic Evidence Review
Evidence-based Practice Center Systematic Review Protocol
Project Title: Achieving Health Equity in Preventive Services – Systematic Evidence Review
I. Background and Objectives for the Systematic Rev…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveillance-report-2.xlsx
January 01, 2021 - Table E-1. RCT QA
Table E-1. RCT quality assessment
Author,
Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Outcome Assessors Masked? Care Provider Masked? Patient Masked? Intention-To-Treat (ITT) Analysis Acceptable Levels of Overall Attrition and Between-Group Differences…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveill-report-1.xlsx
January 01, 2021 - Table E-1. RCT QA
Table E-1. RCT quality assessment
Author,
Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Outcome Assessors Masked? Care Provider Masked? Patient Masked? Intention-to-Treat (ITT) Analysis Acceptable Levels of Overall Attrition and Between-Group Differences…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange_executive.pdf
December 01, 2015 - The one type
of external factor cited as a facilitator was policy in the
form of Federal and State
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nursing-staff-shortages-rapid-research-appendix-c.xlsx
January 01, 2024 - moderate significant correlations with turnover intent (2 studies) or was identified as an important factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-evidence-summary.pdf
October 01, 2021 - Evidence Summary_Comparative Effectiveness Review No. 246_Management of High-Need High-Cost Patients: A "Best Fit" Framework Synthesis, Realist Review, and Systematic Review
Comparative Effectiveness Review
Number 246
Management of High-Need, High-Cost
Patients: A “Best Fit” Framework Synthesis,
Realist Revie…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-disposition-comments.pdf
October 29, 2021 - We have
also heard that
adverse childhood
events can be a risk
factor but we did not
find it as
-
effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
May 29, 2025 - Politi
Slide
1: Supporting
Shared Decisions When Clinical Evidence
is Low
Mary C. Politi, Ph.D.
Department of Surgery, Division of
Public Health Sciences
Washington University in St. Louis School of Medicine
Slide
2: Overview
• Brief overview of Shared Decis…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
January 01, 2012 - Consequences of Comparator
Choice
Confounding
Confounding arises when a risk factor for the
study … mass
index (BMI) is an important potential confounder
because it is a strong and established risk factor … Cancer risk in patients with rheumatoid
arthritis treated with anti–tumor necrosis factor
a therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
September 11, 2015 - metaregressions did not find any
statistically significant differences for moderation by any
program factor … because
behavioral programs seem to preferentially benefit those
with higher baseline HbA1c, this factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
January 01, 2024 - 9 is the use of
dosing protocols and nomograms for newer direct oral anticoagulants (DOACs, e.g.,
factor … otamixaban" [Supplementary Concept] OR "razaxaban"
[Supplementary Concept] OR "Rivaroxaban"[Majr] OR "factor … 37
Making Healthcare Safer IV – Anticoagulant Use
Line # Description String
#5 Factor … Xa
Inhibitors
"Factor Xa Inhibitors"[Majr] OR "antistasin" [Supplementary Concept] OR "apixaban" … otamixaban" [Supplementary Concept] OR "razaxaban" [Supplementary Concept] OR
"Rivaroxaban"[Majr] OR "factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
May 19, 2011 - Evidence-based Practice Center Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 19, 2011
Evidence-based Practice Center Review Protocol
NIH State-of-the-Science Conference:
Role of Active Surveillance in the Management of Men With Localized Prostate Cancer
I. Backg…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - Family History would be important to mention as a clinically
relevant risk factor. … We agree with the reviewer that there is
not consistent evidence for gender as a
CKD risk factor. … We found only
inconsistent data reporting it as a CKD risk
factor, which we tried to reflect in our … We agree that leaving out family history as
a clinical risk factor for CKD was an
oversight. … Renal Data System (USRDS) and the
Behavioral Risk Factor Surveillance System (BRFSS).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
February 07, 2025 - instability-high [MSI-H] or
mismatch repair-deficient [MMR-deficient], claudin, human epidermal growth factor … oxaliplatin and docetaxel; FOLFOX
= leucovorin, fluorouracil, and oxaliplatin; HER2 = human epidermal growth factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amendment.pdf
May 02, 2025 - instability-high [MSI-H] or
mismatch repair-deficient [MMR-deficient], claudin, human epidermal growth factor … oxaliplatin and docetaxel; FOLFOX
= leucovorin, fluorouracil, and oxaliplatin; HER2 = human epidermal growth factor